Zhibao Technology shares surge 12.18% intraday after launching Zhibao Yingshi joint venture with revenue growth targets.

Zhibao Technology surged 12.18% intraday following the announcement of its 51%-owned joint venture, Zhibao Yingshi, which commenced operations in September 2025 to accelerate medical insurance product development. The venture, a collaboration with Yingshi Health, achieved its first revenue in November 2025 from mid- and high-end medical policies and outlined ambitious revenue targets, including RMB 4 million monthly in 2025 and RMB 50 million annually in 2026. Executives highlighted the strategic alignment of resources, with Zhibao leveraging its brokerage expertise and Yingshi’s medical insurance focus to drive growth in the high-margin segment. The joint venture’s forward-looking revenue targets and initial performance signaled confidence in expanding Zhibao’s core MGU (Managing General Underwriter) business, directly boosting investor sentiment.